» Articles » PMID: 31210903

Prevalence of Dysphagia in Multiple Sclerosis and Its Related Factors: Systematic Review and Meta-analysis

Overview
Journal Iran J Neurol
Date 2019 Jun 19
PMID 31210903
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Dysphagia is the most prevalent sign of multiple sclerosis (MS) which can reduce the quality of life and augment mortality in the final stages of MS. We presented a systematic review to estimate the prevalence of dysphagia in general and separately for each evaluation method (subjective and objective), and to analyze the causes of this rampant disease. Cross-sectional and prospective cohort studies were reviewed and scientific proofs were evaluated consistent with the pre-specified levels of certainty. Twenty-two articles entered the meta-analysis phase; the estimation of the general prevalence of dysphagia in MS-affected patients was 43.33% related to all the 22 studies. Moreover, the estimate of the prevalence via the subjective (16 studies) and objective (6 studies) methods were 37.21% and 58.47%, respectively. This study obtained the prevalence rate of dysphagia in patients affected by MS globally, yet there was infinite statistical society and limited methodological quality. Thus, more extensive studies are required for a better understanding of the global epidemiology regarding dysphagia in MS.

Citing Articles

The Comparison of Quality of Life in Patients with Mild-Moderate Severity of Multiple Sclerosis with and without Dysphagia.

Rezatofighi A, Soltani M, Latifi S, Majdinasab N, Safari Z, Varmazyar M Dysphagia. 2025; .

PMID: 40038124 DOI: 10.1007/s00455-025-10811-9.


Risk factors and long-term outcomes of oropharyngeal dysphagia in persons with multiple sclerosis: a systematic review protocol.

Sadeghi Z, Afshar M, Memarian A, Flowers H Syst Rev. 2024; 13(1):121.

PMID: 38698450 PMC: 11067091. DOI: 10.1186/s13643-024-02530-3.


Managing multiple sclerosis in individuals aged 55 and above: a comprehensive review.

Fernandez O, Soelberg Sorensen P, Comi G, Vermersch P, Hartung H, Leocani L Front Immunol. 2024; 15:1379538.

PMID: 38646534 PMC: 11032020. DOI: 10.3389/fimmu.2024.1379538.


Crushing tablets or sprinkling capsules: Implications for clinical strategy and study performance based on BE studies of rivaroxaban and deferasirox.

Sus J, Bosak J, Hauser T Clin Transl Sci. 2024; 17(3):e13752.

PMID: 38511529 PMC: 10955620. DOI: 10.1111/cts.13752.


Estimating the Incidence and Prevalence of Dysphagia in New Zealand.

Duncan S, Menclova A, Huckabee M Dysphagia. 2024; 39(5):808-815.

PMID: 38244042 PMC: 11449997. DOI: 10.1007/s00455-023-10662-2.


References
1.
Thomas F, Wiles C . Dysphagia and nutritional status in multiple sclerosis. J Neurol. 1999; 246(8):677-82. DOI: 10.1007/s004150050431. View

2.
Calcagno P, Ruoppolo G, Grasso M, De Vincentiis M, Paolucci S . Dysphagia in multiple sclerosis - prevalence and prognostic factors. Acta Neurol Scand. 2002; 105(1):40-3. DOI: 10.1034/j.1600-0404.2002.10062.x. View

3.
Wiesner W, Wetzel S, Kappos L, Hoshi M, Witte U, Radue E . Swallowing abnormalities in multiple sclerosis: correlation between videofluoroscopy and subjective symptoms. Eur Radiol. 2002; 12(4):789-92. DOI: 10.1007/s003300101086. View

4.
de Pauw A, Dejaeger E, Dhooghe B, Carton H . Dysphagia in multiple sclerosis. Clin Neurol Neurosurg. 2002; 104(4):345-51. DOI: 10.1016/s0303-8467(02)00053-7. View

5.
Terre-Boliart R, Orient-Lopez F, Guevara-Espinosa D, Ramon-Rona S, Bernabeu-Guitart M, Clave-Civit P . [Oropharyngeal dysphagia in patients with multiple sclerosis]. Rev Neurol. 2004; 39(8):707-10. View